These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effects of angiotensin-converting enzyme gene polymorphism and serum vitamin D levels on ambulatory blood pressure measurement and left ventricular mass in Turkish hypertensive population. Kulah E; Dursun A; Aktunc E; Acikgoz S; Aydin M; Can M; Dursun A Blood Press Monit; 2007 Aug; 12(4):207-13. PubMed ID: 17625392 [TBL] [Abstract][Full Text] [Related]
10. Left ventricular hypertrophy: a potent cardiovascular risk factor and its relationship to office and ambulatory blood pressure. Mansoor GA; Massie BM Blood Press Monit; 1999; 4 Suppl 1():S19-22. PubMed ID: 10822413 [TBL] [Abstract][Full Text] [Related]
11. Home BP for assessing haemodialysis hypertension. Agarwal R Nephrol Dial Transplant; 2007 Oct; 22(10):3089-90; author reply 3090. PubMed ID: 17636055 [No Abstract] [Full Text] [Related]
12. Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults. Handa SP Clin Invest Med; 2006 Dec; 29(6):339-46. PubMed ID: 17330449 [TBL] [Abstract][Full Text] [Related]
13. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients. Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044 [TBL] [Abstract][Full Text] [Related]
14. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension. Verdecchia P; Schillaci G; Borgioni C; Gattobigio R; Ambrosio G; Porcellati C Eur Heart J; 2002 Apr; 23(8):658-65. PubMed ID: 11969281 [TBL] [Abstract][Full Text] [Related]
15. [Ambulatory pulse pressure and left ventricular hypertrophy in patients with essential hypertension]. Cao Y; Zhao SP; Luo L Hunan Yi Ke Da Xue Xue Bao; 2003 Aug; 28(4):379-81. PubMed ID: 14653122 [TBL] [Abstract][Full Text] [Related]
16. Masked hypertension: an independent predictor of organ damage. Cuspidi C; Parati G J Hypertens; 2007 Feb; 25(2):275-9. PubMed ID: 17211231 [No Abstract] [Full Text] [Related]
17. Twenty-four-hour mean heart rate and likelihood of left ventricular hypertrophy. Palmieri V Am J Hypertens; 2006 Feb; 19(2):178. PubMed ID: 16448888 [No Abstract] [Full Text] [Related]
18. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569 [TBL] [Abstract][Full Text] [Related]
19. Ambulatory blood pressure monitoring and target organ damage in pediatrics. Stabouli S; Kotsis V; Zakopoulos N J Hypertens; 2007 Oct; 25(10):1979-86. PubMed ID: 17885534 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment. Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]